Closed Loop Technologies: Pilot and Exploratory Clinical and Behavioral Approaches to Improve Type 1 Diabetes Outcomes (R21)

Post Date

December 8th 2008

Application Due Date

March 19th 2009

Funding Opportunity Number

RFA-DK-08-013

CFDA Number(s)

93.847
93.865

Funding Instrument Type(s)

Grant

Funding Activity Categories

Food and Nutrition
Health
Income Security and Social Services

Eligibility Categories

State Governments
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Estimated Total Funding:

  $2000000

• Award Range:

  $None - $200000

Grant Description

-Purpose . The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health solicit Research Project Grant (R01) applications for human studies to develop a highly reliable, easy to operate system linking continuous glucose monitoring to insulin delivery in a closed loop system.The goal is to address barriers that limit progress toward a closed loop system and specifically to 1) address behavioral factors that limit use of these systems and 2) use the technologies as tools to advance understanding of the pathophysiology of glucose regulation in patients with type 1 diabetes. Research goals include improved metabolic control with decreased glycemic excursions, increased lifestyle flexibility and improved quality of life in patients with diabetes. Only human studies will be considered responsive to this FOA. -Mechanism of Support. This FOA will utilize the R21 grant mechanism and runs in parallel with FOA, RFA-DK-08-012, that solicits applications under the R01 mechanism.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-08-013.html